Phase I study of peptide vaccination in patients with refractory gastrointestinal cancer
Phase 1
- Conditions
- Gastrointestinal cancer
- Registration Number
- JPRN-UMIN000008820
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
1) active double cancer 2) active infection 3) pregnancy, the desire to preserve fecundity, or lactating woman 4) mental disorder 5) steroid treatment 6) uncontrolled diabetes mellitus 7) unstable angina or myocardial infarction within 6 months 8) other severe complications 9) active bleeding 10) massive ascites 11) massive pleural effusion 12) HBs antigen-positive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate dose-limiting toxicity and immune response
- Secondary Outcome Measures
Name Time Method